139 related articles for article (PubMed ID: 33718220)
1. Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells
Li W; Xu S; Peng N; Zhang Z; He H; Chen R; Chen D; Fan J; Wang X
Front Oncol; 2021; 11():634542. PubMed ID: 33718220
[TBL] [Abstract][Full Text] [Related]
2. METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer.
Liu D; Li W; Zhong F; Yin J; Zhou W; Li S; Sun X; Xu J; Li G; Wen Y; Wang J; Hong M; Cheng Z; Yuan J; Dai L; Sun J; Wang J; Qiu C; Wang G; Zou C
Front Pharmacol; 2020; 11():178. PubMed ID: 32180726
[TBL] [Abstract][Full Text] [Related]
3. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
6. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
7. METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expression.
Xu L; Peng B; Wu H; Zheng Y; Yu Q; Fang S
Metab Brain Dis; 2022 Apr; 37(4):1133-1143. PubMed ID: 35254598
[TBL] [Abstract][Full Text] [Related]
8. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
[TBL] [Abstract][Full Text] [Related]
9. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells.
Li R; Mu C; Cao Y; Fan Y
Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989
[TBL] [Abstract][Full Text] [Related]
10. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma.
Feng G; Ma HM; Huang HB; Li YW; Zhang P; Huang JJ; Cheng L; Li GR
Cancer Manag Res; 2019; 11():1263-1274. PubMed ID: 30799953
[TBL] [Abstract][Full Text] [Related]
12. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
13. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma.
Chen X; Li C; Li Y; Wu S; Liu W; Lin T; Li M; Weng Y; Lin W; Qiu S
Front Mol Biosci; 2021; 8():727481. PubMed ID: 34604305
[TBL] [Abstract][Full Text] [Related]
14. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
16. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
Front Oncol; 2021; 11():650534. PubMed ID: 33996568
[TBL] [Abstract][Full Text] [Related]
17. PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation.
Tao T; Yang X; Zheng J; Feng D; Qin Q; Shi X; Wang Q; Zhao C; Peng Z; Liu H; Jiang WG; He J
Oncogene; 2017 Nov; 36(44):6119-6131. PubMed ID: 28692056
[TBL] [Abstract][Full Text] [Related]
18. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
19. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition.
Ye D; Jiang Y; Sun Y; Li Y; Cai Y; Wang Q; Wang O; Chen E; Zhang X
J Mol Endocrinol; 2019 Jul; 63(1):51-61. PubMed ID: 31121562
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Chin J Cancer Res; 2014 Aug; 26(4):371-81. PubMed ID: 25232208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
